Hasanov, M., Milton, D. R., Sharfman, W. H., Taback, B., Cranmer, L. D., Daniels, G. A., Flaherty, L., Hallmeyer, S., Milhem, M., Feun, L., Hauke, R., Doolittle, G., Gregory, N., & Patel, S. (2021). An Open–Label, Randomized, Multi–Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin–2) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma. OncoImmunology, 10(1). https://doi.org/10.1080/2162402x.2021.1984059